Inhibition of Cold VarIant of Influenza Virus by Selected Chemicals

References

• Fenner F The Biology of Animal Viruses New York Academic Press Inc 1968 2 598 602
   Google Scholar
• Dubes GR Chapin M Cold-adapted genetic variants of polio viruses Science 1956 124 586 588
   PubMed Web of Science ®Google Scholar
• Sabin AB Recent studies and field tests with a live attenuated poliovirus vaccine, in Live Poliovirus Vaccines Scientific publication Pan American Sanitary Bureau Washington 44 1959 14 33
   Google Scholar
• Plotkin SA Norton TW Cohen BJ A type 3 attenuated poliovirus genetically stable after human intestinal passage Proc Soc Exp Biol Med 107 829 834 1961
   PubMed Web of Science ®Google Scholar
• Rohitayodhin S Hammon WM Studies on Japanese B encephalitis virus vaccine from tissue culture: II. Development of an attenuated strain of virus J Immun 1962 89 589 597
   PubMedGoogle Scholar
• Hozinski VI Seibil VB Pantelyeva NS The rct40 and T 50 markers and the characteristics of somE’ valiants of measles virus Acta Virol 10 20 27 1968
   Web of Science ®Google Scholar
• Maassab HF Adaptation and growth characterif-jes of influenza virus at 25°c Nature 1967 213 612 614
   PubMed Web of Science ®Google Scholar
• Maassab HF Biologic and immunologic characteristics of cold-adapted influenza virus J Immun 1969 102 728 732
   PubMed Web of Science ®Google Scholar
• Schmidt NJ Tissue culture methods and procedures for diagnostic virology Lennette EH Schmidt NJ Diagnostic Procedure for Viral and Rickettsial Diseases New York American Public Health Association Inc 1964 78 176 3
   Google Scholar
• Goedemans WT Peters A Quantitative he·madsorption: A fast and reliable screening test for anti-myxoviral agents 4rch Ges Virusforsch 1968 23 326 331
   PubMedGoogle Scholar
• Berlin BS Cochran KW Delay of fatal pneumonia in x-irradiated mice inoculated with mouse influenza, PR8 strain Radiat Res 1967 31 343 351
   PubMed Web of Science ®Google Scholar
• Horsfall FL Jr: Neutralization of epidemic influenza virus J Exp Med 1939 70 209 222
   PubMedGoogle Scholar
• Ho PPK Walters CP Streightoff F In vivo activity of an inhibitor of influenza virus-induced ribonucleic acid polymerase Antimicrob Agents Chemother 1967 1968 636 641
   Google Scholar
• Hoffmann CE Neumayer EM Haft RF Mode of action of the antiviral activity of amantadine in tissue culture J Bact 1965 90 623 628
   PubMed Web of Science ®Google Scholar
• Davies WL Grunert RR Haff RF Antiviral activity of 1-adamantanamine (amantadine) Science 1964 144 862 863
   PubMed Web of Science ®Google Scholar
• Cochran KW Maassab HF Tsunoda A Studies on the antiviral activity of amantadine hydrochloride Ann NY Acad Sci 1965 130 432 439
   PubMed Web of Science ®Google Scholar
• Sinsheimer JE Subba Hao G McIlhenny HM Isolation and antiviral activity of the gymnemic acids. Experentia 24 1968 302 303
   Google Scholar
• Bell WC Maassab HF Action of hydroxyurea on multiplication of influenza virus in mammalian cells Nature 217 1968 646 647
   PubMed Web of Science ®Google Scholar
• Kato N Eggers HJ Inhibition of uncoating of fowl plague virus by l-adamantanamine hydrochloride Virology 1969 37 632 641
   PubMed Web of Science ®Google Scholar
• Scholtissek C Rott R Effect of temperature on the multiplication of an influenza virus J Gen Virol 1969 5 283 290
   PubMed Web of Science ®Google Scholar
• Rosenberg B Van Camp L Krigas T Inhibition of cell division in Escherischia coli by electrolysis products from a platinum electrode Nature 205 1965 698 699
   Google Scholar
• Rosenberg B Van Camp L Trosko JE Platinum compounds: A new class of potent antitumour agents Nature 1969 222 385 386
   PubMed Web of Science ®Google Scholar
• Richardson M Suppression by platinum compounds and other chemical agents of the Brucella antibody response elicited in vitro Proc Tissue Cult Assoc 1969 20 41
   Google Scholar